Effects of Streptolysin o, Picibanil (OK 432) and Interferon α2A on Cytochrome P-450-Dependent Monooxygenases and Arylamine N-Acetyltransferase in Rat Liver

References

• Renton K. W., Mannering G. J. Depression of Hepatic Cytochrome P-450-Dependent Monooxygenase System with Administration of Interferon Inducing Agents. Biochem. Biophys. Res. Commun. 1976; 73: 343
   PubMed Web of Science ®Google Scholar
• Mannering G. J., Renton K. W., El Azhary R., Deloria L. B. Effects of Interferon-Inducing Agents on Hepatic Cytochrome P-450 Drug Metabolising Systems. Ann. NY. Acad. Sci. 1980; 350: 314
   PubMedGoogle Scholar
• Descotes J. Immunoraodulating Agents and Hepatic Drug-Metabolising Enzymes. Drug Metab. Rev. 1985; 16: 175
   PubMed Web of Science ®Google Scholar
• Mannering G. J., Deloria L. B. The Pharmacology and Toxicology of Interferons: An Overview. Ann. Rev. Pharmacol. Toxicol. 1986; 26: 455
   PubMed Web of Science ®Google Scholar
• Farquhar D., Loo T. L., Gutterman J. U., Hersi E. M., Luna M. A. Inhibition of Drug Metabolising Enzymes in the Rat after Bacillus Calmette-Guerin Treatment. Biochem. Pharmacol. 1976; 25: 1529
   PubMed Web of Science ®Google Scholar
• Farquhar D., Benvenuto J. A., Kuttesch N., Loo T. L. Inhibition of Hepatic Drug Metabolism in the Rat after Corynebacteriura Parvum Treatment. Biochem. Pharmacol. 1983; 32: 1275
   PubMed Web of Science ®Google Scholar
• Matsuura Y., Watanabe H., Fukuda T., Yoshida T., Kuroiwa Y. A sustained Increase of Microsomal Heme Oxygenase Activity Following Treatment of Rats with Bacillus Calmette-Gudrin and Corynebacterium Parvum: its Possible Relation to the Decrease of Cytochrome P-450 Content. J. Pharmacobiodyn. 1985; 8: 669
   PubMedGoogle Scholar
• Soyka L. F., Hunt W. G., Knight S. E., Foster R. S., Jr. Decreased Liver and Lung Drug-Metabolising Activity in Mice Treated with Corynebacterium Parvum. Cancer. Res. 1976; 36: 4425
   PubMedGoogle Scholar
• Gorodisher R., Krasner J., McDevitt J. J., Nolan J., Yaffe S. J. Hepatic Microsomal Drug Metabolism after Administration of Endotoxin in Rats. Biochem. Pharmacol. 1976; 25: 351
   PubMedGoogle Scholar
• Williams J. Induction of Tolerance in Mice and Rats to the Effect of Endotoxin to Decrease the Hepatic Microsomal MFO System. Int. J. Immunopharmacol. 1985; 7: 501
   PubMedGoogle Scholar
• Williams J. F., Szentivanyi A. Depression of Hepatic Drug Metabolising Enzyme Activity by B. Pertussis Vaccination. Eur. J. Pharmacol. 1977; 43: 281
   PubMedGoogle Scholar
• Azri S., Renton K. W. Depression of Murine Hepatic Mixed Function Oxidase during Infection with Listeria Monocytogenes. J. Pharmacol. Exp. Ther. 1987; 243: 1089
   PubMed Web of Science ®Google Scholar
• Azri S., Renton K. W. Factors Involved in the Depression of Hepatic Mixed Function Oxidase During Infections with Listeria Monocytogenes. Int. J. Immunopharmacol. 1991; 13: 197
   PubMedGoogle Scholar
• Armstrong S., Renton K. W. The Effect of Listeria Monocytogenes Infection on Cytochrome P-450-Mediated Metabolism. Eur. J. Pharmacol. 1990; 183/4: 1361
   Google Scholar
• Hojo H., Hashimoto Y. Inhibition of Drug Metabolising Enzymes in the Mouse after Treatment with Host-Mediating Antitumor Agents. Toxicol. Lett. 1977; 1: 89
   Google Scholar
• Hadaová E., Siegmund W., Franke G., Schneider T., Beyrich A., Bleyer H., Hübner G. Drug Oxidation and N-Acetylation in Rats Pretreated with Subtoxic Dosis of Streptolysin 0. Biochem. Pharmacol. 1991; 42: 702
   PubMedGoogle Scholar
• Dolphin C. T., Caldwell J., Smith R. L. Effect of Interferon Synthesis upon the Metabolism of (Carboxyl-14C)-Aspirin in the Mouse. Biochem. Pharmacol. 1987; 36: 2437
   PubMedGoogle Scholar
• Notter D., Roland E. Localisation of N-Acetyltransferase in Sinusoidal Liver Cells. Effect of Zymosan on the Acetylation of Sulfamethazine and Isoniazid in the Rat and in Isolated Perfused Liver. C. R. Soc. Biol. 1978; 172: 531
   PubMedGoogle Scholar
• Zídek Z., Janku I. Increased Acetylation of Sulphadimidine in Rats with Adjuvant Induced Arthritis. Eur. J. Drug. Metab. Pharmacokin. 1981; 6: 225
   PubMedGoogle Scholar
• Zídek Z., Friebová M., Janku I., Elis J. Influence of Sex and Freund's Adjuvant on Liver N-Acetyltransferase Activity and Elimination of Sulphadimidine in Urine of Rats. Biochem. Pharmacol. 1977; 26: 69
   PubMed Web of Science ®Google Scholar
• Du Souich P., Courteau H. Induction of Acetylating Capacity with Complete Freund's Adjuvant and Hydrocortisone in the Rabbit. Drug Metab. Dispos. 1981; 9: 279
   PubMed Web of Science ®Google Scholar
• Hadaová E., Gulda O. Streptolysin O-Induced Changes in Elimination of Drugs and their Acetylmetabolites in the Rat. Scripta Medica Fac. Med. Brunensis 1985; 58: 504
   Google Scholar
• Hadaová E., Bryová V., Gulda O. Study on the Acetylation Activity in Various Species In Vivo and its Affection with Streptolysin 0. J. Pharmacol. (Paris) 1986; 17: 181
   Google Scholar
• Hadaová E., Gulda O., Rovensk J. Analysis of Some Pharmacological and Immunological Activities of Low Doses of Streptolysin O. Toxicon 1987; 25: 369
   Google Scholar
• Siegmund Hada W., Ová E., Franke G., Bleyer H., Hübner G. Sublytic Doses of Streptolysin O -Effects on the Metabolic Fate of Procainamide in Rats. Pharmazie 1991; 46: 676
   PubMedGoogle Scholar
• Svensson C. K., Knowlton P. W. Effect of Immunomodulator Tilorone on the In Vivo Acetylation of Procainamide in the Rat. Pharmac. Res. 1989; 6: 477
   PubMed Web of Science ®Google Scholar
• Drobitsch R. K., Tomilo M., Svensson C. K. Immunomodulation and Drug Acetylation: Influence of the Immunomodulator Tilorone on Hepatic, Renal and Blood N-Acetyltransferase Activity and on Hepatic Cytosolic Coenzyme A Content. Biochem. Pharmacol. 1992; 43: 1643
   PubMedGoogle Scholar
• Renton K. W., Singh G., Stebbing N. Relationship Between the Antiviral Effects of Interferons and their Abilities to Depress Cytochrome P-450. Biochem. Pharmacol. 1984; 33: 3899
   PubMed Web of Science ®Google Scholar
• Franklin M. R., Fincle B. S. Effect of Murine GammaInterferon on the Mouse Liver and its Drug-Metabolising Enzymes: Comparison with Human Hybrid Alpha-Interferon. J. Interferon Res. 1985; 5: 265
   PubMedGoogle Scholar
• Moochhala S. M., Renton K. W., Stebbing N. Induction and Depression of Cytochrome P-450-Dependent Mixed-Function Oxidase by a Cloned Consensus Alpha-Interferon (IFN-alpha CON1) in the Hamster. Biochem. Pharmacol. 1989; 38: 439
   PubMed Web of Science ®Google Scholar
• Stanley L. A., Adams D. J., Balkwill F. R., Griffin D., Wolf C. R. Differential Effects of Recombinant Interferon Alpha on Constitutive and Inducible Cytochrome P-450 Isoenzymes in Mouse Liver. Biochem. Pharmacol. 1991; 42: 311
   PubMed Web of Science ®Google Scholar
• Greim H. Synthesesteigerung und Abbauhemmung bei der Vermehrung der mikrosomalen Cytochrome P-450 und b5 durch Phenobarbital. Naunyn Schmiedeberg's Arch. Pharmakol. 1970; 266
   Google Scholar
• Schenkmann J. B., Remmer H., Estabrook R. W. Spectral Studies of Drug Interaction with Hepatic Microsomal Cytochrome. Mol. Pharmacol. 1967; 3: 113
   PubMed Web of Science ®Google Scholar
• Nash T. The Colorimetric Estimation of Formaldehyde by Means of the Hantzsch Reaction. Biochem. J. 1953; 55: 416
   PubMed Web of Science ®Google Scholar
• Greenlee W. F., Poland A. An Improved Assay of 7-Ethoxycoumarin O-Deethylase Activity: Induction of Hepatic Enzyme Activity in C57BL/6J and DBA/2J Mice by Phenobarbital, 3-Methylcholanthrene and 2, 3, 7, 8-Tetrachlorodibenzo-p-Dioxin. J. Pharmacol. Exp. Ther. 1978; 205: 596
   PubMed Web of Science ®Google Scholar
• Burke M. D., Prough R. A., Mayer R. T. Characteristics of Microsomal Cytochrome P-448-Mediated Reaction. Ethoxyresorufin O-de-Ethylation. Drug Metab. Dispos. 1977; 5: 1
   PubMed Web of Science ®Google Scholar
• Niedermeyer W. Interaction of Streptolysin-O with Biomembranes: Kinetic and Morphological Studies on Erythrocyte Membranes. Toxicon 1985; 23: 425
   PubMedGoogle Scholar
• Duncan J. L. Liposomes as Membrane Models in Studies of Bacterial Toxins. J. Toxicol.-Toxin. Reviews 1984; 3: 1
   Google Scholar
• Hadaová E. Pharmacokinetics of Phenazone in Rats after the Administration of a Sublytic Dose of Streptolysin O (Czech), Cs. Fysiol. 1990; 39: 134
   Google Scholar
• Canalias F., Viver J., Beleta J., Gonzales-Sastre F., Gella F. J. Purification and Characterisation of Streptolysin O from Streptococcus Pyogenes. Int. J. Biochem. 1992; 24: 1073
   PubMedGoogle Scholar
• Jonkman J. H. G., Nicholson K. G., Farrow P. R., Eckert M., Grasmeijer G., Oosterhuis B., De Noord O. E., Guentert T. W. Effects of α-Interferon on Theophylline Pharmacokinetics and Metabolism. Br. J. clin. Pharmac 1989; 27: 795
   PubMed Web of Science ®Google Scholar
• Peterson T., Renton K. W. Kupffer Cell Factor Mediated Depression of Hepatic Parenchymal Cell Cytochrome P-450. Biochem. Pharmacol. 1986; 35: 1491
   PubMed Web of Science ®Google Scholar
• Moochala S. M. Alteration of Drug Biotransformation by Interferon and Host Defence Mechanism. Ann. Acad. Med. Singapore 1991; 20: 13
   PubMedGoogle Scholar
• Finter N. B. The Assay and Standardisation of Interferon and Interferon Inducers. Interferon and Interferon Inducers, 2nd edition. North-Holland, Amsterdam 1973; 135
   Google Scholar
• Matsubara S., Suzuki F., Ishida N. Induction of Immune Interferon in Mice Treated with a Bacterial Immunopotentiator, OK 432. Cancer Immunol. Immunother. 1979; 6: 41
   Web of Science ®Google Scholar
• Craig P. I., Williams S. J., Cantrill E., Farrell G. C. Rat but not Human Interferons Suppress Hepatic Oxidative Drug Metabolismus in Rats. Gastroenterology 1989; 97: 999
   PubMed Web of Science ®Google Scholar
• Craig P. I., Murray M., Farrell G. C. Interferon Suppresses the Isoform-Specific Activities of Hepatic Cytochrome P450 in Female Rats. Biochem. Pharmacol. 1992; 43: 908
   PubMed Web of Science ®Google Scholar
• Alouf J. E., Raynaud M. Purification and some Properties of Streptolysin O. Biochimie 1973; 55: 1187
   PubMedGoogle Scholar
• Watson K. C., Kerr E. J. Specificity of Antibodies for t Sites and f Sites of Streptolysin O. J. Med. Microbiol. 1985; 19: 1
   PubMedGoogle Scholar